Skip to main content

Publication, Part of

Cancer survival: Index for Clinical Commissioning Groups, 2004 to 2019

Current Chapter

Cancer survival: Index for Clinical Commissioning Groups, 2004 to 2019


Summary

This release summarises the 1-year cancer survival by Clinical Commissioning Group (CCG) for all cancers combined from 2004 to 2019 and followed up to 2020. The index of cancer survival provides a convenient, single number that summarises the overall pattern of cancer survival for each calendar year. We additionally present 1-year net survival estimates for breast, colorectal and lung cancers. The index has been designed to compare levels of survival over time for individual CCGs (rather than comparing between CCGs) – interpretation should focus on overall trends rather than on small changes in the survival index in a particular year.


Key Facts

1-year index of cancer survival for England has increased

The 1-year index of cancer survival for England has increased from 64.4% in 2004 to 74.6% in 2019

Geographic variation in the index of cancer survival has narrowed

The variation in the index of cancer survival between the Clinical Commissioning Groups (CCGs) narrowed, with the range in survival estimates reducing from 9.4 percentage points in 2004 to 7.8 percentage points in 2019

Geographic variation in net survival narrowed for breast and colorectal cancer, but not lung cancer

The range in net survival estimates between CCGs  decreased from 11.0 percentage points in 2004 to 4.8 percentage points in 2019 for breast cancer, decreased from 17.2 percentage points in 2004 to 12.7 percentage points in 2019 for colorectal cancer, but increased from 13.0 percentage points in 2004 to 17.5 percentage points in 2019 for lung cancer

Acknowledgements

This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data is collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of NHS Digital.

On 1 October 2021, responsibility for the National Disease Registration Service (NDRS) transferred from Public Health England (PHE) to NHS Digital. NHS Digital is the data controller for this data. The National Cancer Registration and Analysis Service (NCRAS) as part of the NDRS is still responsible for collecting data on patients with cancer in England and continues to produce the cancer statistics publications.

Previous releases of these statistics can be found at the Cancer Survival in England Collection link below.




Last edited: 31 March 2022 9:31 am